secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0000950170-23-027743
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bolt Biotherapeutics annual meeting elects three directors, ratifies PwC as auditor
--------------------------------------------------------------------------------

- Randall C. Schatzman, Ph.D. elected with 18,339,155 votes for, 49,830 withheld.
- Edgar G. Engleman, M.D. elected with 18,300,413 votes for, 88,572 withheld.
- James I. Healy, M.D., Ph.D. elected with 14,449,941 votes for, 3,939,044 withheld.
- Ratification of PricewaterhouseCoopers LLP as auditor for FY2023: 26,831,426 for, 33,439 against, 15,578 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000095017023027743/0000950170-23-027743-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000095017023027743/bolt-20230612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027743

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer